Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

HTLV-1 sweet-talks its way into cells

HTLV-1 infection poses a risk for leukemia and other ailments. Now the elusive cellular receptor for this pathogen has finally been identified, and it is the same receptor that allows glucose to enter cells.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Possible roles for GLUT-1 in HTLV-1 infection.


  1. Poiesz, B.J. et al. Proc. Natl. Acad. Sci. USA 77, 7415–7419 (1980).

    CAS  Article  Google Scholar 

  2. Manel, N. et al. Cell 115, 449–459 (2003).

    CAS  Article  Google Scholar 

  3. Overbaugh, J., Miller, A.D. & Eiden, M.V. Microbiol. Mol. Biol. Rev. 65, 371–389 (2001).

    CAS  Article  Google Scholar 

  4. Manel, N. et al. Blood 101, 1913–1918 (2003).

    CAS  Article  Google Scholar 

  5. Nath, M.D. et al. Blood 101, 3085–3092 (2003).

    CAS  Article  Google Scholar 

  6. Sommerfelt, M.A. & Weiss, R.A. Virology 176, 58–69 (1990).

    CAS  Article  Google Scholar 

  7. Stoye, J.P. Proc. Natl. Acad. Sci. USA 99, 11549–11551 (2002).

    CAS  Article  Google Scholar 

  8. Igakura, T. et al. Science 299, 1713–1715 (2003).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and Permissions

About this article

Cite this article

Overbaugh, J. HTLV-1 sweet-talks its way into cells. Nat Med 10, 20–21 (2004).

Download citation

  • Issue Date:

  • DOI:

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing